A £60 million superstar has been signed. Medicals will be conducted today at London Colney. A 4-year contract has been finalized, and the unveiling will take place within the next 24 hours.
Chelsea Secures £60 Million Superstar over Arsenal: Details on Medicals, Contract, and Unveiling
Chelsea has successfully outbid Arsenal for the signing of a £60 million superstar. Medical examinations are scheduled for today at London Colney, and the player has already signed a 4-year contract. The official unveiling will occur within the next 24 hours.
Chelsea has been linked with Napoli striker Victor Osimhen since last summer, and Enzo Maresca has now decided to move forward with the deal.
Smith predicts a “last-minute rush” in the transfer window, but a €120 million offer from Chelsea to Napoli is not expected to be part of it.
Reports suggest Napoli has lowered the asking price for the Nigerian international. Chelsea might include a player in the deal due to financial constraints.
In his column for CaughtOffside, super-agent Jon Smith mentioned Chelsea’s interest in Osimhen, despite the focus being broad. Smith indicated that a move for Osimhen remains a possibility, especially after the Euros, when clubs will have had the chance to sell players and raise funds.
Earlier reports today suggest a move for Osimhen hasn’t been completely ruled out, provided Napoli reduces their high asking price, which is expected for a top-tier striker in his prime.
Despite Smith’s insights, the Osimhen deal currently seems unlikely from our perspective. Chelsea had pursued him intensively for years, with frequent reports about their scouts monitoring him and discussions on what it would take to convince Napoli to sell. However, interest appears to have waned over the past six months.
Chelsea is reluctant to spend the necessary money on transfer fees and wages for Osimhen, especially after his relatively poor season by his high standards. This hesitation is a significant factor in the club’s decision-making process.
As Chelsea looks forward to other market opportunities, they may gradually abandon the Osimhen deal.